Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel

NCT04826484 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

104

Enrollment

OTHER

Sponsor class

Stopped Met futility threshold at interim analysis

Conditions

Urologic Diseases
Hypospadias
Undescended Testes
Chordee
Hydrocele
Orchiectomy

Interventions

DRUG: Exparel 133 miligrams per 10 milliliter injection
DRUG: Bupivacaine Hydrochloride

Sponsor

Johns Hopkins University